The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Alpha Emitters-Global Market Insights and Sales Trends 2025
Synopsis
Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues than beta-emitters and this particle action has caught the market attention.
The global Alpha Emitters market size is expected to reach US$ 1946.2 million by 2029, growing at a CAGR of 20.8% from 2023 to 2029. The market is mainly driven by the significant applications of Alpha Emitters in various end use industries. The expanding demands from the Hospitals, Medical Research Institutions and Others,, are propelling Alpha Emitters market. Terbium (Tb-149), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Astatine (At-211) segment is estimated at % CAGR for the next seven-year period.
The market for alpha-emitters in the United States is growing rapidly. The United States accounted for the largest global market share in 2017. The high-end research trend in the United States, coupled with high investments in healthcare research and abundant knowledge in cancer research, is the key factor propelling the growth of the market in this country.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alpha Emitters, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alpha Emitters market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alpha Emitters market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alpha Emitters sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alpha Emitters covered in this report include Bayer, Alpha Tau Medical, IBA RadioPharma, Actinium Pharmaceuticals, Telix Pharmaceuticals, RadioMedix and Fusion Pharmaceuticals, etc.
The global Alpha Emitters market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Alpha Tau Medical
IBA RadioPharma
Actinium Pharmaceuticals
Telix Pharmaceuticals
RadioMedix
Fusion Pharmaceuticals
Global Alpha Emitters market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alpha Emitters market, Segment by Type:
Terbium (Tb-149)
Astatine (At-211)
Bismuth (Bi-212)
Actinium (Ac-225)
Radium (Ra-223)
Lead (Pb-212)
Bismuth (Bi-213)
Global Alpha Emitters market, by Application
Hospitals
Medical Research Institutions
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Alpha Emitters companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues than beta-emitters and this particle action has caught the market attention.
The global Alpha Emitters market size is expected to reach US$ 1946.2 million by 2029, growing at a CAGR of 20.8% from 2023 to 2029. The market is mainly driven by the significant applications of Alpha Emitters in various end use industries. The expanding demands from the Hospitals, Medical Research Institutions and Others,, are propelling Alpha Emitters market. Terbium (Tb-149), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Astatine (At-211) segment is estimated at % CAGR for the next seven-year period.
The market for alpha-emitters in the United States is growing rapidly. The United States accounted for the largest global market share in 2017. The high-end research trend in the United States, coupled with high investments in healthcare research and abundant knowledge in cancer research, is the key factor propelling the growth of the market in this country.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alpha Emitters, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alpha Emitters market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alpha Emitters market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alpha Emitters sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alpha Emitters covered in this report include Bayer, Alpha Tau Medical, IBA RadioPharma, Actinium Pharmaceuticals, Telix Pharmaceuticals, RadioMedix and Fusion Pharmaceuticals, etc.
The global Alpha Emitters market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Alpha Tau Medical
IBA RadioPharma
Actinium Pharmaceuticals
Telix Pharmaceuticals
RadioMedix
Fusion Pharmaceuticals
Global Alpha Emitters market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alpha Emitters market, Segment by Type:
Terbium (Tb-149)
Astatine (At-211)
Bismuth (Bi-212)
Actinium (Ac-225)
Radium (Ra-223)
Lead (Pb-212)
Bismuth (Bi-213)
Global Alpha Emitters market, by Application
Hospitals
Medical Research Institutions
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Alpha Emitters companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Alpha Emitters
1.1 Alpha Emitters Market Overview
1.1.1 Alpha Emitters Product Scope
1.1.2 Alpha Emitters Market Status and Outlook
1.2 Global Alpha Emitters Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Alpha Emitters Market Size by Region (2018-2029)
1.4 Global Alpha Emitters Historic Market Size by Region (2018-2023)
1.5 Global Alpha Emitters Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Alpha Emitters Market Size (2018-2029)
1.6.1 North America Alpha Emitters Market Size (2018-2029)
1.6.2 Europe Alpha Emitters Market Size (2018-2029)
1.6.3 Asia-Pacific Alpha Emitters Market Size (2018-2029)
1.6.4 Latin America Alpha Emitters Market Size (2018-2029)
1.6.5 Middle East & Africa Alpha Emitters Market Size (2018-2029)
2 Alpha Emitters Market by Type
2.1 Introduction
2.1.1 Terbium (Tb-149)
2.1.2 Astatine (At-211)
2.1.3 Bismuth (Bi-212)
2.1.4 Actinium (Ac-225)
2.1.5 Radium (Ra-223)
2.1.6 Lead (Pb-212)
2.1.7 Bismuth (Bi-213)
2.2 Global Alpha Emitters Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Alpha Emitters Historic Market Size by Type (2018-2023)
2.2.2 Global Alpha Emitters Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Alpha Emitters Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Alpha Emitters Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Alpha Emitters Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Alpha Emitters Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Alpha Emitters Revenue Breakdown by Type (2018-2029)
3 Alpha Emitters Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Medical Research Institutions
3.1.3 Others
3.2 Global Alpha Emitters Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Alpha Emitters Historic Market Size by Application (2018-2023)
3.2.2 Global Alpha Emitters Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Alpha Emitters Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Alpha Emitters Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Alpha Emitters Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Alpha Emitters Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Alpha Emitters Revenue Breakdown by Application (2018-2029)
4 Alpha Emitters Competition Analysis by Players
4.1 Global Alpha Emitters Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alpha Emitters as of 2022)
4.3 Date of Key Players Enter into Alpha Emitters Market
4.4 Global Top Players Alpha Emitters Headquarters and Area Served
4.5 Key Players Alpha Emitters Product Solution and Service
4.6 Competitive Status
4.6.1 Alpha Emitters Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Alpha Emitters Products, Services and Solutions
5.1.4 Bayer Alpha Emitters Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer Recent Developments
5.2 Alpha Tau Medical
5.2.1 Alpha Tau Medical Profile
5.2.2 Alpha Tau Medical Main Business
5.2.3 Alpha Tau Medical Alpha Emitters Products, Services and Solutions
5.2.4 Alpha Tau Medical Alpha Emitters Revenue (US$ Million) & (2018-2023)
5.2.5 Alpha Tau Medical Recent Developments
5.3 IBA RadioPharma
5.3.1 IBA RadioPharma Profile
5.3.2 IBA RadioPharma Main Business
5.3.3 IBA RadioPharma Alpha Emitters Products, Services and Solutions
5.3.4 IBA RadioPharma Alpha Emitters Revenue (US$ Million) & (2018-2023)
5.3.5 Actinium Pharmaceuticals Recent Developments
5.4 Actinium Pharmaceuticals
5.4.1 Actinium Pharmaceuticals Profile
5.4.2 Actinium Pharmaceuticals Main Business
5.4.3 Actinium Pharmaceuticals Alpha Emitters Products, Services and Solutions
5.4.4 Actinium Pharmaceuticals Alpha Emitters Revenue (US$ Million) & (2018-2023)
5.4.5 Actinium Pharmaceuticals Recent Developments
5.5 Telix Pharmaceuticals
5.5.1 Telix Pharmaceuticals Profile
5.5.2 Telix Pharmaceuticals Main Business
5.5.3 Telix Pharmaceuticals Alpha Emitters Products, Services and Solutions
5.5.4 Telix Pharmaceuticals Alpha Emitters Revenue (US$ Million) & (2018-2023)
5.5.5 Telix Pharmaceuticals Recent Developments
5.6 RadioMedix
5.6.1 RadioMedix Profile
5.6.2 RadioMedix Main Business
5.6.3 RadioMedix Alpha Emitters Products, Services and Solutions
5.6.4 RadioMedix Alpha Emitters Revenue (US$ Million) & (2018-2023)
5.6.5 RadioMedix Recent Developments
5.7 Fusion Pharmaceuticals
5.7.1 Fusion Pharmaceuticals Profile
5.7.2 Fusion Pharmaceuticals Main Business
5.7.3 Fusion Pharmaceuticals Alpha Emitters Products, Services and Solutions
5.7.4 Fusion Pharmaceuticals Alpha Emitters Revenue (US$ Million) & (2018-2023)
5.7.5 Fusion Pharmaceuticals Recent Developments
6 North America
6.1 North America Alpha Emitters Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Alpha Emitters Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Alpha Emitters Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Alpha Emitters Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Alpha Emitters Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Alpha Emitters Market Dynamics
11.1 Alpha Emitters Industry Trends
11.2 Alpha Emitters Market Drivers
11.3 Alpha Emitters Market Challenges
11.4 Alpha Emitters Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
